Impact of methotrexate on first-dose COVID-19 mRNA vaccination

Caoilfhionn M. Connolly, Julie J. Paik

Research output: Contribution to journal › Comment/debate › peer-review

ASJC Scopus subject areas

@article{53b6bd3ca5ff4536b8b1c8376b22d725,

title = "Impact of methotrexate on first-dose COVID-19 mRNA vaccination",

author = "Connolly, {Caoilfhionn M.} and Paik, {Julie J.}",

year = "2021",

month = sep,

doi = "10.1016/S2665-9913(21)00217-4",

language = "English (US)",

volume = "3",

pages = "e607--e609",

journal = "The Lancet Rheumatology",

issn = "2665-9913",

publisher = "Elsevier Ltd",

number = "9",

}

TY - JOUR

T1 - Impact of methotrexate on first-dose COVID-19 mRNA vaccination

AU - Connolly, Caoilfhionn M.

AU - Paik, Julie J.

PY - 2021/9

Y1 - 2021/9

UR - http://www.scopus.com/inward/record.url?scp=85113324469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85113324469&partnerID=8YFLogxK

U2 - 10.1016/S2665-9913(21)00217-4

DO - 10.1016/S2665-9913(21)00217-4

M3 - Comment/debate

AN - SCOPUS:85113324469

SN - 2665-9913

VL - 3

SP - e607-e609

JO - The Lancet Rheumatology

JF - The Lancet Rheumatology

IS - 9

ER -